Regenerative medicine-based anti-aging can be broadly categorized into four approaches:

The first is the tissue repair type, represented by PRP (Platelet-Rich Plasma). It utilizes growth factors derived from autologous platelets to promote tissue repair and improve skin condition. It is suitable for individuals with dull, fatigued, or post-procedure recovery needs, although its effects are typically cumulative over time.

The second is the cellular signaling type, such as exosomes (Exosome). This approach works by mediating intercellular communication to regulate inflammation and optimize the tissue repair environment. It may benefit fatigued skin and early signs of aging, though product quality and consistency can vary significantly.

The third is the regenerative remodeling type, such as Profhilo Structura. It combines collagen stimulation with structural support to improve laxity and volume loss, emphasizing overall rejuvenation and a naturally firm appearance.

The fourth is advanced cellular therapy, including stem cell-related or NK cell-related applications. These approaches fall under systemic health management and advanced anti-aging strategies, but are subject to more stringent regulatory and clinical eligibility constraints.

Overall, regenerative medicine for anti-aging progresses through a continuum of “repair → modulation → reconstruction → systemic optimization,” with treatment selection depending on the individual’s degree of aging and specific needs.